Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹115 Cr₹11,271,608 Cr₹126 Cr₹123 Cr₹123 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹115 Cr based on Mar2023 Consolidated results.
Year Revenue
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr
Mar2021₹126 Cr
Mar2020₹123 Cr
Mar2019₹123 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr
8,980,974.92
Mar2021 ₹126 Cr
2.37
Mar2020 ₹123 Cr
0.00
Mar2019 ₹123 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹735.5 Cr 33.4% 51% -17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

33.4%

51%

-17%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses